Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women

PloS One
Lap Ah TseXiaohong Rose Yang

Abstract

The role of family history to the risk of breast cancer was analyzed by incorporating menopausal status in Hong Kong Chinese women, with a particular respect to the estrogen receptor-positive (ER+) type. Seven hundred and forty seven breast cancer incident cases and 781 hospital controls who had completed information on family cancer history in first-degree relatives (nature father, mother, and siblings) were recruited. Odds ratio for breast cancer were calculated by unconditional multiple logistic regression, stratified by menopausal status (a surrogate of endogenous female sex hormone level and age) and type of relative affected with the disease. Further subgroup analysis by tumor type according to ER status was investigated. Altogether 52 (6.96%) breast cancer cases and 23 (2.95%) controls was found that the patients' one or more first-degree relatives had a history of breast cancer, showing an adjusted odds ratio (OR) of 2.41 (95%CI: 1.45-4.02). An excess risk of breast cancer was restricted to the ER+ tumor (OR = 2.43, 95% CI: 1.38-4.28), with a relatively higher risk associated with an affected mother (OR = 3.97, 95%CI: 1.46-10.79) than an affected sister (OR = 2.06, 95%CI: 1.07-3.97), while the relative risk was more pro...Continue Reading

References

May 1, 1992·American Journal of Epidemiology·S WacholderJ S Mandel
Oct 15, 1988·International Journal of Cancer. Journal International Du Cancer·S C TaoK W Xiu
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·B NewmanM C King
Nov 1, 1985·American Journal of Epidemiology·P BruzziC Schairer
May 29, 1997·International Journal of Cancer. Journal International Du Cancer·P D PharoahB A Ponder
Feb 26, 2000·Carcinogenesis·B E Henderson, H S Feigelson
May 1, 2001·Nature Medicine·K L NathansonK N Nathanson
Aug 15, 2002·British Journal of Cancer·T M MackE B Rappaport
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Steven R CummingsJane A Cauleys
Sep 28, 2005·Cancer Detection and Prevention·Jennifer A RusieckiTongzhang Zheng
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·B A J PonderP D P Pharoah
Mar 23, 2010·Journal of the National Cancer Institute·Jonine L BernsteinUNKNOWN WECARE Study Collaborative Group
Jul 11, 2014·Breast Cancer Research and Treatment·Bo ZhangZhen-dong Chen

❮ Previous
Next ❯

Methods Mentioned

BETA
hormone replacement therapy
biopsy

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Athena MatakidouRichard S Houlston
International Journal of Cancer. Journal International Du Cancer
P D PharoahB A Ponder
Breast Cancer Research : BCR
Douglas F Easton
Breast Cancer : the Journal of the Japanese Breast Cancer Society
M KanamoriT Izuno
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Eva NegriCarlo La Vecchia
© 2022 Meta ULC. All rights reserved